Oncology Drug Development

Explore our cutting-edge oncology drug discovery projects in development.

SB1000's Pipeline

SB1000's are a group of candidates in drug development that are advancing therapies targeting brain tumors with innovative drug delivery systems, enhancing efficacy and reducing side effects for patients suffering from aggressive cancers. These drugs use proven existing off-patent chemical agents, kill switches and antibodies with innovative SB platform technology that delivers drugs to the intended target in the brain cancer treatment.

Our SB1000's program was selected to be part of the very first NCI STEP cohort. If you are interested to partner with us - Inquire Here

SB3000's Pipeline

SB3000's focuses on developing breakthrough treatments for various Central Nervous System (CNS) disorders, utilizing proprietary SB platform technology to improve drug transport across the blood-brain barrier, aiming for better patient outcomes and quality of life.

Write to us to learn more

Innovative Oncology Drug Discovery Solutions

We specialize in developing cutting-edge oncology therapies, inspired by leaders in the field to develop our SB1000's and SB3000's candidate compunds, focusing on transformative treatments for cancer patients worldwide.

Transforming cancer treatment through innovation.

Oncology Drug Development

"

Contact Us

Reach out for inquiries about our oncology drug discovery pipeline.